Literature DB >> 7195723

[A controlled clinical trial for testing the efficacy of the homeopathic drug eupatorium perfoliatum D2 inthe treatment of common cold (author's transl)].

C A Gassinger, G Wünstel, P Netter.   

Abstract

53 outpatients suffering from common cold (flu) were randomly assigned to either a therapy with acetylsalicylic acid (ASA) or the homeopathic drug Eupatorium perfoliatum D2 in a controlled clinical trial. The efficacy of the drugs was assessed on day 1, 4 and 10 of the infection by symptom check lists and physical examinations. Neither subjective complaints nor body temperature or laboratory findings showed any significant differences between groups which was taken as evidence that both drugs were equally effective.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195723

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

1.  A controlled evaluation of a homoeopathic preparation in the treatment of influenza-like syndromes.

Authors:  J P Ferley; D Zmirou; D D'Adhemar; F Balducci
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

2.  The comprehensiveness of Medline and Embase computer searches. Searches for controlled trials of homoeopathy, ascorbic acid for common cold and ginkgo biloba for cerebral insufficiency and intermittent claudication.

Authors:  J Kleijnen; P Knipschild
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

3.  Clinical trials of homoeopathy.

Authors:  J Kleijnen; P Knipschild; G ter Riet
Journal:  BMJ       Date:  1991-02-09

4.  Immunology and homeopathy. 4. Clinical studies-part 1.

Authors:  Paolo Bellavite; Riccardo Ortolani; Francesco Pontarollo; Valeria Piasere; Giovanni Benato; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-05       Impact factor: 2.629

5.  Immunology and homeopathy. 4. Clinical studies-part 2.

Authors:  Paolo Bellavite; Riccardo Ortolani; Francesco Pontarollo; Valeria Piasere; Giovanni Benato; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-31       Impact factor: 2.629

6.  Caffeic acid derivatives from Eupatorium perfoliatum L.

Authors:  Mareike Maas; Frank Petereit; Andreas Hensel
Journal:  Molecules       Date:  2008-12-23       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.